Engineering recombinant immune checkpoint proteins for antibody drug development

16 Aug 2022

In this scientific poster, ACROBiosystems presents a series of examples of recombinant protein engineering for antibody drug development guided by their structural, biological, and biochemical properties.

Immune Checkpoint Proteins

ACROBiosystems

ACROBiosystems has developed a full range of immune checkpoint proteins, including co-inhibitory receptors, co-stimulatory receptors, inhibitor screening kits, and others.

(0)

Links

Tags

Engineering recombinant immune checkpoint proteins for antibody drug development